Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medicus Pharma Ltd.MDCX · Entity 7770 | 10% owner | December 31, 2024 | May 21, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medicus Pharma Ltd.
Report date December 31, 2024 · Filed May 21, 2025 · Amendment
Jointly reported with VELOCITY FUND PARTNERS, LP
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Shares, no par value ("Common Shares")SEC Table I · non-derivative | IndirectSee Footnote | 2,914,330 |
Reported balance
Holding disclosure · report date 2024-12-31 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 2,914,330 F1: Held by Velocity Fund Partners, LP, an entity controlled by Dr. Kenneth R. Melani. Dr. Kenneth R. Melani disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
| Common SharesSEC Table I · non-derivative | Direct | 409,411 |
Reported balance
Holding disclosure · report date 2024-12-31 · row 2
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 2 · Balance 409,411 |
Filing footnotes · ownership attribution and instrument terms
F1: Held by Velocity Fund Partners, LP, an entity controlled by Dr. Kenneth R. Melani. Dr. Kenneth R. Melani disclaims beneficial ownership except to the extent of his pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 20, 2025 Filed May 21, 2025 12:57 UTC | Medicus Pharma Ltd. MDCX · Entity 7770 | SaleMedicus Pharma LTD | 75,000 | $7.72 | $578,940.00 |
DisclosureSEC source: 0001671948-25-000005 · primary_doc.xml · nonDerivative · entry 1 VELOCITY FUND PARTNERS, LP · CIK 0001671948 · 10% owner Melani Kenneth R. · CIK 0002050471 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 3,248,741 F1 · kind: The common shares were sold by Velocity Fund Partners, LP pursuant to an open market sale of 75,000 common shares on May 20, 2025 at a net price per common share of $7.7192. F2 · ownership.nature: Represents 2,839,330 common shares held by Velocity Fund Partners, LP an entity controlled by Dr. Kenneth R. Melani and 409,411 common shares held directly by Dr. Kenneth R. Melani. Dr. Kenneth R. Melani disclaims beneficial ownership of common shares held by Velocity Fund Partners, LP, except to the extent of his pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.